family_id
int64 1
1.1k
| family_type
stringclasses 9
values | family_name
stringclasses 590
values | target_id
int64 1
3.29k
| target_name
stringlengths 3
122
| interaction_id
int64 1
90.9k
| interaction_type
stringclasses 10
values | interaction_action
stringclasses 24
values | primary_target
bool 2
classes | affinity_median
float64 0.3
13
⌀ | affinity_units
stringclasses 7
values | ligand_id
int64 1
13.4k
| ligand_name
stringlengths 2
141
| ligand_type
stringclasses 6
values | ligand_approved
bool 2
classes | ligand_approval_source
stringclasses 439
values | pubchem_sid
float64 53.8M
491M
⌀ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 85,476 | Inhibitor | Inhibition | false | null | - | 10,056 | dapansutrile | Synthetic organic | false | null | 375,973,244 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 88,900 | Inhibitor | Inhibition | false | 6.85 | pIC50 | 12,172 | emlenoflast | Synthetic organic | false | null | 472,319,294 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 89,015 | Allosteric modulator | Inhibition | false | 7.29 | pIC50 | 12,280 | GDC-2394 | Synthetic organic | false | null | 473,153,868 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 81,832 | Inhibitor | Inhibition | false | 8 | pIC50 | 8,228 | MCC950 | Synthetic organic | false | null | 249,565,908 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 90,152 | Inhibitor | Inhibition | false | 7.18 | pIC50 | 13,009 | NDT-19795 | Synthetic organic | false | null | 485,206,130 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 90,526 | Inhibitor | Inhibition | false | null | - | 13,184 | nibrozetone | Synthetic organic | false | null | 491,299,966 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 90,732 | Inhibitor | Inhibition | false | 7.96 | pIC50 | 13,338 | NT-0249 | Synthetic organic | false | null | null |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 90,151 | Inhibitor | Inhibition | false | 9.49 | pIC50 | 13,008 | NT-0796 | Synthetic organic | false | null | 485,206,129 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 90,243 | Inhibitor | Inhibition | false | 7.28 | pKd | 13,088 | oridonin | Natural product | false | null | 491,299,870 |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 90,860 | Inhibitor | Inhibition | false | 7.11 | pIC50 | 13,421 | oridonin derivative 32 [PMID: 38751194] | Synthetic organic | false | null | null |
317 | catalytic_receptor | NOD-like receptor family | 1,770 | NLRP3 | 88,901 | Inhibitor | Inhibition | false | 6 | pIC50 | 12,173 | selnoflast | Synthetic organic | false | null | 472,319,295 |
317 | catalytic_receptor | NOD-like receptor family | 1,766 | NLRX1 | 90,801 | Activator | Activation | false | 4.52 | pKd | 13,384 | amelenodor | Synthetic organic | false | null | null |
317 | catalytic_receptor | NOD-like receptor family | 1,762 | nucleotide binding oligomerization domain containing 1 | 13,475 | Agonist | Agonist | null | null | - | 5,021 | meso-DAP | Natural product | false | null | 178,101,718 |
317 | catalytic_receptor | NOD-like receptor family | 1,762 | nucleotide binding oligomerization domain containing 1 | 83,011 | Inhibitor | Inhibition | true | 6.25 | pIC50 | 8,887 | ML130 | Synthetic organic | false | null | 310,264,668 |
317 | catalytic_receptor | NOD-like receptor family | 1,763 | nucleotide binding oligomerization domain containing 2 | 83,012 | Inhibitor | Inhibition | false | 4.7 | pIC50 | 8,887 | ML130 | Synthetic organic | false | null | 310,264,668 |
317 | catalytic_receptor | NOD-like receptor family | 1,763 | nucleotide binding oligomerization domain containing 2 | 13,476 | Agonist | Agonist | null | null | - | 5,024 | muramyl dipeptide | Natural product | false | null | 178,101,721 |
309 | catalytic_receptor | Prolactin receptor family | 1,718 | Eythropoietin receptor | 84,592 | Agonist | Agonist | true | null | - | 9,677 | cibinetide | Peptide | false | null | 348,353,636 |
309 | catalytic_receptor | Prolactin receptor family | 1,718 | Eythropoietin receptor | 13,431 | Agonist | Agonist | false | 11.15 | pIC50 | 4,921 | erythropoietin | Peptide | true | FDA (no history prior to 1989 available) | 178,101,620 |
309 | catalytic_receptor | Prolactin receptor family | 1,718 | Eythropoietin receptor | 79,747 | Agonist | Agonist | true | 10.43 | pIC50 | 7,447 | peginesatide | Peptide | true | FDA (2012) | 178,104,019 |
309 | catalytic_receptor | Prolactin receptor family | 1,719 | Granulocyte colony-stimulating factor receptor | 88,337 | Antibody | Binding | true | 8.85 | pKd | 11,761 | anumigilimab | Antibody | false | null | 458,923,796 |
309 | catalytic_receptor | Prolactin receptor family | 1,719 | Granulocyte colony-stimulating factor receptor | 88,338 | Antibody | Binding | false | 9.31 | pKd | 11,761 | anumigilimab | Antibody | false | null | 458,923,796 |
309 | catalytic_receptor | Prolactin receptor family | 1,719 | Granulocyte colony-stimulating factor receptor | 13,432 | Agonist | Agonist | null | null | - | 4,934 | G-CSF | Peptide | true | null | 178,101,632 |
309 | catalytic_receptor | Prolactin receptor family | 1,719 | Granulocyte colony-stimulating factor receptor | 79,223 | Agonist | Agonist | true | null | - | 6,969 | pegfilgrastim | Peptide | true | FDA and EMA (2002) | 178,103,549 |
309 | catalytic_receptor | Prolactin receptor family | 1,720 | Growth hormone receptor | 13,433 | Agonist | Agonist | true | 9.04 | pKd | 4,943 | growth hormone 1 | Peptide | true | FDA (1976), EMA (2001) | 178,101,641 |
309 | catalytic_receptor | Prolactin receptor family | 1,720 | Growth hormone receptor | 13,434 | Agonist | Agonist | null | null | - | 4,944 | growth hormone 2 | Peptide | false | null | 178,101,642 |
309 | catalytic_receptor | Prolactin receptor family | 1,720 | Growth hormone receptor | 79,795 | Antagonist | Antagonist | true | null | - | 7,485 | pegvisomant | Peptide | true | FDA (2003), EMA (2008) | 187,051,788 |
309 | catalytic_receptor | Prolactin receptor family | 1,720 | Growth hormone receptor | 88,698 | Agonist | Agonist | false | 8.29 | pKd | 12,013 | somatrogon | Peptide | true | EMA (2022), FDA (2023) | 464,244,154 |
309 | catalytic_receptor | Prolactin receptor family | 1,720 | Growth hormone receptor | 88,697 | Agonist | Agonist | false | 8.2 | pKd | 12,013 | somatrogon | Peptide | true | EMA (2022), FDA (2023) | 464,244,154 |
309 | catalytic_receptor | Prolactin receptor family | 1,720 | Growth hormone receptor | 88,699 | Agonist | Agonist | false | 7.94 | pKd | 12,013 | somatrogon | Peptide | true | EMA (2022), FDA (2023) | 464,244,154 |
309 | catalytic_receptor | Prolactin receptor family | 1,721 | Prolactin receptor | 77,615 | Agonist | Agonist | null | null | - | 4,893 | choriomammotropin | Peptide | false | null | 178,101,593 |
309 | catalytic_receptor | Prolactin receptor family | 1,721 | Prolactin receptor | 77,616 | Agonist | Agonist | null | null | - | 4,894 | chorionic somatomammotropin hormone-like 1 | Peptide | false | null | 178,101,594 |
309 | catalytic_receptor | Prolactin receptor family | 1,721 | Prolactin receptor | 77,614 | Agonist | Agonist | false | 8.05 | pKd | 5,049 | prolactin | Peptide | false | null | 178,101,744 |
309 | catalytic_receptor | Prolactin receptor family | 1,722 | Thrombopoietin receptor | 85,215 | Agonist | Agonist | false | null | - | 9,953 | avatrombopag | Synthetic organic | true | FDA (2018), EMA (2019) | 374,883,840 |
309 | catalytic_receptor | Prolactin receptor family | 1,722 | Thrombopoietin receptor | 79,046 | Agonist | Agonist | true | 7.42 | pEC50 | 6,961 | eltrombopag | Synthetic organic | true | FDA (2008), EMA (2010) | 178,103,542 |
309 | catalytic_receptor | Prolactin receptor family | 1,722 | Thrombopoietin receptor | 87,052 | Agonist | Agonist | false | null | - | 10,657 | hetrombopag | Synthetic organic | true | China (2021) | 404,859,104 |
309 | catalytic_receptor | Prolactin receptor family | 1,722 | Thrombopoietin receptor | 85,433 | Agonist | Agonist | true | null | - | 10,032 | lusutrombopag | Synthetic organic | true | Japan (2015), FDA (2018), EMA (2019) | 375,973,220 |
309 | catalytic_receptor | Prolactin receptor family | 1,722 | Thrombopoietin receptor | 79,045 | Agonist | Agonist | true | null | - | 6,974 | romiplostim | Peptide | true | FDA (2008), EMA (2009) | 178,103,553 |
309 | catalytic_receptor | Prolactin receptor family | 1,722 | Thrombopoietin receptor | 13,436 | Agonist | Agonist | null | null | - | 5,063 | thrombopoietin | Peptide | false | null | 178,101,756 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,851 | RTP Type B | 82,785 | Inhibitor | Inhibition | false | 7.15 | pIC50 | 8,786 | compound 13e [PMID: 16759857] | Synthetic organic | false | null | 252,827,444 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,851 | RTP Type B | 87,728 | Inhibitor | Inhibition | false | 6.15 | pIC50 | 11,336 | razuprotafib | Synthetic organic | false | null | 440,816,705 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,853 | RTP Type D | 85,643 | Inhibitor | Inhibition | true | null | pIC50 | 10,109 | 7-BIA | Synthetic organic | false | null | 381,118,819 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,855 | RTP Type F | 82,742 | Inhibitor | Inhibition | false | 5.89 | pIC50 | 8,770 | illudalic acid | Synthetic organic | false | null | 252,827,428 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,856 | RTP Type G | 82,872 | Inhibitor | Inhibition | false | 5.6 | pKi | 8,831 | compound 1 [PMID: 21882820] | Synthetic organic | false | null | 252,827,488 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,860 | RTP Type M | 82,925 | Inhibitor | Inhibition | false | 5.15 | pIC50 | 8,856 | compound 8a [PMID: 23713581] | Synthetic organic | false | null | 252,827,513 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,866 | RTP Type S | 85,644 | Inhibitor | Inhibition | false | 4.4 | pIC50 | 10,109 | 7-BIA | Synthetic organic | false | null | 381,118,819 |
333 | catalytic_receptor | Receptor tyrosine phosphatase (RTP) family | 1,866 | RTP Type S | 82,915 | Inhibitor | Inhibition | false | 5.44 | pIC50 | 8,850 | compound 7b [Haftchenary <i>et al.</i>, 2013] | Synthetic organic | false | null | 252,827,507 |
940 | catalytic_receptor | RIG-I-like receptor family | 2,920 | DExD/H-box helicase 58 | 88,378 | Agonist | Agonist | false | null | - | 11,795 | SLR14 | Synthetic organic | false | null | 458,923,830 |
797 | catalytic_receptor | RSTK functional heteromers | 2,588 | Activin receptors | 79,955 | Agonist | Agonist | false | null | - | 4,857 | activin A | Peptide | false | null | 178,101,558 |
797 | catalytic_receptor | RSTK functional heteromers | 2,588 | Activin receptors | 79,958 | Agonist | Agonist | false | null | - | 4,858 | activin AB | Peptide | false | null | 178,101,559 |
797 | catalytic_receptor | RSTK functional heteromers | 2,588 | Activin receptors | 79,956 | Agonist | Agonist | false | null | - | 4,859 | activin B | Peptide | false | null | 178,101,560 |
797 | catalytic_receptor | RSTK functional heteromers | 2,588 | Activin receptors | 79,957 | Agonist | Agonist | false | null | - | 5,010 | inhibin A | Peptide | false | null | 178,101,707 |
797 | catalytic_receptor | RSTK functional heteromers | 2,589 | Anti-Müllerian hormone receptors | 78,668 | Agonist | Agonist | null | null | - | 6,686 | Müllerian inhibiting substance | Peptide | false | null | 178,103,298 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,661 | Agonist | Agonist | null | null | - | 4,875 | BMP-10 | Peptide | false | null | 178,101,575 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,653 | Agonist | Agonist | null | null | - | 4,881 | BMP-2 | Peptide | false | null | 178,101,581 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,654 | Agonist | Agonist | null | null | - | 4,883 | BMP-4 | Peptide | false | null | 178,101,583 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,655 | Agonist | Agonist | null | null | - | 4,884 | BMP-5 | Peptide | false | null | 178,101,584 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,656 | Agonist | Agonist | null | null | - | 4,885 | BMP-6 | Peptide | false | null | 178,101,585 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,657 | Agonist | Agonist | null | null | - | 4,886 | BMP-7 | Peptide | false | null | 178,101,586 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,658 | Agonist | Agonist | null | null | - | 4,887 | BMP-8A | Peptide | false | null | 178,101,587 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,659 | Agonist | Agonist | null | null | - | 4,888 | BMP-8B | Peptide | false | null | 178,101,588 |
797 | catalytic_receptor | RSTK functional heteromers | 2,586 | Bone morphogenetic protein receptors | 78,660 | Agonist | Agonist | null | null | - | 4,889 | BMP-9 | Peptide | false | null | 178,101,589 |
797 | catalytic_receptor | RSTK functional heteromers | 2,587 | Growth/differentiation factor receptors | 78,662 | Agonist | Agonist | null | null | - | 4,936 | growth/differentiation factor-1 | Peptide | false | null | 178,101,634 |
797 | catalytic_receptor | RSTK functional heteromers | 2,587 | Growth/differentiation factor receptors | 78,665 | Agonist | Agonist | null | null | - | 4,937 | growth/differentiation factor-10 | Peptide | false | null | 178,101,635 |
797 | catalytic_receptor | RSTK functional heteromers | 2,587 | Growth/differentiation factor receptors | 78,663 | Agonist | Agonist | null | null | - | 4,938 | growth/differentiation factor-3 | Peptide | false | null | 178,101,636 |
797 | catalytic_receptor | RSTK functional heteromers | 2,587 | Growth/differentiation factor receptors | 81,905 | Agonist | Agonist | false | null | - | 4,877 | growth/differentiation factor-7 | Peptide | false | null | 178,101,577 |
797 | catalytic_receptor | RSTK functional heteromers | 2,587 | Growth/differentiation factor receptors | 78,664 | Agonist | Agonist | null | null | - | 4,939 | growth/differentiation factor-9 | Peptide | false | null | 178,101,637 |
797 | catalytic_receptor | RSTK functional heteromers | 2,585 | Transforming growth factor β receptor | 78,650 | Agonist | Agonist | null | null | - | 5,060 | TGFβ1 | Peptide | false | null | 178,101,753 |
797 | catalytic_receptor | RSTK functional heteromers | 2,585 | Transforming growth factor β receptor | 78,651 | Agonist | Agonist | null | null | - | 5,061 | TGFβ2 | Peptide | false | null | 178,101,754 |
797 | catalytic_receptor | RSTK functional heteromers | 2,585 | Transforming growth factor β receptor | 78,652 | Agonist | Agonist | null | null | - | 5,062 | TGFβ3 | Peptide | false | null | 178,101,755 |
316 | catalytic_receptor | Toll-like receptor family | 1,752 | TLR2 | 83,029 | Agonist | Agonist | false | 7.6 | pKi | 8,888 | compound 13 [PMID: 23098072] | Synthetic organic | false | null | 310,264,669 |
316 | catalytic_receptor | Toll-like receptor family | 1,752 | TLR2 | 83,394 | Agonist | Agonist | false | null | - | 9,024 | defoslimod | Synthetic organic | false | null | 315,661,109 |
316 | catalytic_receptor | Toll-like receptor family | 1,752 | TLR2 | 86,260 | Agonist | Agonist | false | 9.96 | pEC50 | 10,341 | diprovocim-1 | Synthetic organic | false | null | 381,745,022 |
316 | catalytic_receptor | Toll-like receptor family | 1,752 | TLR2 | 13,464 | Agonist | Agonist | null | null | - | 5,044 | peptidoglycan | Natural product | false | null | 178,101,739 |
316 | catalytic_receptor | Toll-like receptor family | 1,752 | TLR2 | 84,052 | Antibody | Binding | false | 7.92 | pKd | 9,408 | tomaralimab | Antibody | false | null | 328,083,510 |
316 | catalytic_receptor | Toll-like receptor family | 1,752 | TLR2 | 84,051 | Antibody | Binding | true | 7.54 | pKd | 9,408 | tomaralimab | Antibody | false | null | 328,083,510 |
316 | catalytic_receptor | Toll-like receptor family | 1,753 | TLR3 | 13,465 | Agonist | Agonist | null | null | - | 5,047 | poly(I:C) | Synthetic organic | false | null | 178,101,742 |
316 | catalytic_receptor | Toll-like receptor family | 1,754 | TLR4 | 85,558 | Agonist | Partial agonist | false | null | - | 10,091 | CRX-555 | Synthetic organic | false | null | 381,118,801 |
316 | catalytic_receptor | Toll-like receptor family | 1,754 | TLR4 | 83,395 | Agonist | Agonist | false | null | - | 9,024 | defoslimod | Synthetic organic | false | null | 315,661,109 |
316 | catalytic_receptor | Toll-like receptor family | 1,754 | TLR4 | 87,398 | Agonist | Agonist | false | 9.77 | pEC50 | 11,150 | GSK1795091 | Synthetic organic | false | null | 434,122,210 |
316 | catalytic_receptor | Toll-like receptor family | 1,754 | TLR4 | 13,466 | Agonist | Agonist | null | null | - | 5,019 | LPS | Natural product | false | null | 178,101,716 |
316 | catalytic_receptor | Toll-like receptor family | 1,754 | TLR4 | 84,390 | Agonist | Agonist | false | null | - | 9,137 | neoceptin-3 | Synthetic organic | false | null | 315,661,222 |
316 | catalytic_receptor | Toll-like receptor family | 1,754 | TLR4 | 13,467 | Agonist | Agonist | false | null | - | 2,770 | paclitaxel | Natural product | true | FDA (1992), EMA (2008) | 135,652,721 |
316 | catalytic_receptor | Toll-like receptor family | 1,754 | TLR4 | 83,405 | Antagonist | Antagonist | true | null | - | 9,036 | resatorvid | Synthetic organic | false | null | 315,661,121 |
316 | catalytic_receptor | Toll-like receptor family | 1,755 | TLR5 | 13,468 | Agonist | Agonist | false | null | - | 4,931 | flagellin | Natural product | false | null | 178,101,629 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 83,397 | Agonist | Agonist | false | 5.21 | pEC50 | 9,025 | 852A | Synthetic organic | false | null | 315,661,110 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 83,396 | Agonist | Agonist | false | 5.58 | pEC50 | 9,025 | 852A | Synthetic organic | false | null | 315,661,110 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 86,594 | Antagonist | Antagonist | false | 5.09 | pIC50 | 10,435 | compound 10a [PMID: 31283223] | Synthetic organic | false | null | 385,612,195 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 88,657 | Agonist | Agonist | false | 3.42 | pEC50 | 11,977 | compound 27 [WO2019226977A1] | Synthetic organic | false | null | 464,244,118 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 87,657 | Antagonist | Antagonist | false | 6 | pIC50 | 11,307 | enpatoran | Synthetic organic | false | null | 434,321,742 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 83,732 | Agonist | Agonist | true | null | - | 9,254 | GSK2245035 | Synthetic organic | false | null | 315,661,329 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 79,583 | Antagonist | Antagonist | true | 5.56 | pIC50 | 7,198 | hydroxychloroquine | Synthetic organic | true | FDA (1955) | 178,103,773 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 13,470 | Agonist | Agonist | true | 4.94 | pEC50 | 5,003 | imiquimod | Synthetic organic | true | FDA (1997), EMA (1998) | 178,101,700 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 13,471 | Agonist | Agonist | null | null | - | 5,018 | loxoribine | Synthetic organic | false | null | 178,101,715 |
316 | catalytic_receptor | Toll-like receptor family | 1,757 | TLR7 | 13,469 | Agonist | Agonist | false | 5.87 | pEC50 | 5,051 | resiquimod | Synthetic organic | false | null | 178,101,746 |
316 | catalytic_receptor | Toll-like receptor family | 1,758 | TLR8 | 83,750 | Agonist | Agonist | true | 5.88 | pEC50 | 9,270 | 3M-002 | Synthetic organic | false | null | 315,661,345 |
316 | catalytic_receptor | Toll-like receptor family | 1,758 | TLR8 | 84,634 | Agonist | Agonist | true | 5.3 | pEC50 | 9,690 | compound 12p [Larson <i>et al.</i>, 2017] | Synthetic organic | false | null | 348,353,649 |
316 | catalytic_receptor | Toll-like receptor family | 1,758 | TLR8 | 88,668 | Antagonist | Antagonist | false | 8.7 | pIC50 | 11,989 | compound 15 [PMID: 35450354] | Synthetic organic | false | null | 464,244,130 |
316 | catalytic_receptor | Toll-like receptor family | 1,758 | TLR8 | 84,826 | Inhibitor | Inhibition | false | 6.66 | pKd | 9,795 | CU-CPT8m | Synthetic organic | false | null | 354,702,267 |
316 | catalytic_receptor | Toll-like receptor family | 1,758 | TLR8 | 84,825 | Inhibitor | Inhibition | false | 7.17 | pIC50 | 9,795 | CU-CPT8m | Synthetic organic | false | null | 354,702,267 |
316 | catalytic_receptor | Toll-like receptor family | 1,758 | TLR8 | 83,398 | Agonist | Agonist | false | 7 | pEC50 | 9,026 | motolimod | Synthetic organic | false | null | 315,661,111 |